Der Homocystinurie-Markt wird bis 2028 voraussichtlich 73,96 Millionen US-Dollar erreichen, gegenüber 56,58 Millionen US-Dollar im Jahr 2021; Es wird geschätzt, dass sie zwischen 2021 und 2028 mit einer durchschnittlichen jährlichen Wachstumsrate von 3,9 % wächst.
Homocystinurie ist eine genetische Erkrankung, bei der der Körper bestimmte Proteinbausteine (Aminosäuren) nicht richtig verdauen kann. Homocystinurie gibt es in verschiedenen Formen, jede mit ihren eigenen Anzeichen und Symptomen sowie einer erblichen Ätiologie. Kurzsichtigkeit (Myopie), Luxation der Linse an der Vorderseite des Auges, ein erhöhtes Risiko einer unregelmäßigen Blutgerinnung und brüchige Knochen, die zu Brüchen (Osteoporose) oder anderen Skelettanomalien neigen, sind die häufigsten Formen der Homocystinurie. Einige der betroffenen Menschen haben auch Entwicklungsverzögerungen und Lernschwierigkeiten.
Strategische Erkenntnisse
Das Wachstum des Homocystinurie-Marktes wird auf den zunehmenden Mangel an Vitamin B6 und Vitamin B12 zurückgeführt die zunehmende Prävalenz erblicher Stoffwechselstörungen. Allerdings behindert das mangelnde Bewusstsein für verschiedene seltene Erkrankungen und erbliche Stoffwechselstörungen das Marktwachstum.
Lukrative Regionen im Homocystinurie-Markt
MarkteinblickeSteigende Vitamin-B6- und Vitamin-B12-Mängel treiben den Homocystinurie-Markt an< /h3>
Die Zunahme der Mangelmuster an Vitamin B6 und Vitamin B12 führt zu verschiedenen Erkrankungen wie Anämie, megaloblastischer Anämie, mikrozytischer Anämie und einigen Arten von Stoffwechselstörungen, was das Marktwachstum im Prognosezeitraum ankurbeln dürfte. Da davon ausgegangen wird, dass die Vitamin-B6-Therapie eine wirksame Therapie gegen Homocystinurie ist, kann ein Mangel an diesem Vitamin den Zustand verschlimmern. Pyridoxin (Vitamin B6) fungiert als Cofaktor der Beta-Synthase und fungiert als Chaperon zur Stabilisierung mehrerer Missense-Mutationen. Einige der Patienten mit Homocystinurie sprechen gut auf eine Pyridoxintherapie an und sie hilft, den Homocysteinspiegel zu senken und so die Erkrankung zu lindern. Daher gilt Vitamin B6 als entscheidend für die Behandlung von Homocystinurie, da nur eine begrenzte Anzahl von Behandlungsmöglichkeiten zur Heilung der Erkrankung zur Verfügung steht. Der Mangel an diesem Enzym führt zu Anämie und mikrozytärer Anämie. Es wird erwartet, dass die zunehmende Prävalenz von Anämie das Marktwachstum im Prognosezeitraum ankurbeln wird. Nach Angaben der Weltgesundheitsorganisation sind beispielsweise über 1,62 Milliarden Menschen, also 24,8 % der Bevölkerung, von Anämie betroffen. Die Hauptursachen für Anämie sind falsche Ernährung und ein Mangel an Vitaminen wie B6, B9 und B12. Vor allem Vitamin-B6-Mangel ist eine der Hauptursachen für Anämie. Daher wird erwartet, dass ein Anstieg der Fälle von Vitamin-B6-Mangel und eine hohe Prävalenz von mit diesem Mangel verbundenen Störungen das Marktwachstum im Prognosezeitraum unterstützen werden.
Methodenbasierte Erkenntnisse
The Der globale Homocystinurie-Markt ist methodisch in Behandlung und Diagnostik unterteilt. Das Behandlungssegment hielt im Jahr 2021 einen größeren Marktanteil. Darüber hinaus wird erwartet, dass dasselbe Segment im Prognosezeitraum aufgrund der etablierten Nutzung von Behandlungen und der zunehmenden Forschung und Entwicklung neuer Behandlungen für Homocystinurie eine höhere CAGR auf dem Markt verzeichnen wird.
Homocystinurie-Markt nach Methode 2021 und 2028
Endbenutzerbasierte Erkenntnisse
Der globale Homocystinurie-Markt ist nach Endbenutzern segmentiert Diagnostik- und Bildgebungslabore, Krankenhäuser und Kliniken, Spezialkliniken sowie akademische und Forschungsinstitute. Im Jahr 2021 hielt das Segment Diagnostik- und Bildgebungslabore den größten Marktanteil. Darüber hinaus wird erwartet, dass das Segment im Zeitraum 20212028 die höchste CAGR von 4,2 % verzeichnen wird, da in Diagnostik- und Bildgebungslabors immer häufiger diagnostizierte erbliche Stoffwechselstörungen diagnostiziert werden.
Produkteinführungen und -zulassungen sind gängige Strategien von Unternehmen ihre globale Präsenz und ihr Produktportfolio zu erweitern. Darüber hinaus konzentrieren sich die Akteure auf dem Homocystinurie-Markt auf die Partnerschaftsstrategie, um ihren Kundenkreis zu vergrößern, was ihnen wiederum ermöglicht, ihren Markennamen auf der ganzen Welt aufrechtzuerhalten.
Der Bericht segmentiert den Homocystinurie-Markt wie folgt
Homocystinurie-Markt nach Methode
- Behandlung
- Pyridoxin
- Betain
- Andere
- Diagnostik
- Gentests
- Aminosäure-Screening-Test
- Leberenzymtest
- Andere
< /ul>
Homocystinurie-Markt nach Endbenutzer
- Krankenhäuser und Kliniken
- Diagnose- und Bildgebungslabore
- Spezialkliniken
- Akademische und Forschungsinstitute
Homocystinurie-Markt nach Geografie
- Nordamerika
- USA< /li>
- Kanada
- Mexiko
- Europa
- Großbritannien
- Deutschland
- Frankreich
- Italien
- Spanien
- Restliches Europa
- Asien-Pazifik
- China
- Japan
- Indien
- Australien
- Südkorea
- Übriger Asien-Pazifik
li>
- Naher Osten und Afrika
- VAE
- Saudi-Arabien
- Südafrika
- Rest des Nahen Ostens und Afrikas
- Süd- und Mittelamerika
- Brasilien
- Argentinien
- Übriger Süden und Mittelamerika
Unternehmensprofile
- BASF SE
- HUAZHONG PHARMACEUTICAL
- Pfizer Inc.
- MYLAN NV
- Aeglea BioTherapeutics
- Amino GMBH
- KAO Corporation
- DSM Corporation< /li>
- Orphan Technologies
- Fresenius Kabi AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global Homocystinuria market is expected to reach US$ 73,960.22 thousand by 2028 from US$ 56,589.20 thousand in 2021; it is estimated to grow at a CAGR of 3.9% during 2021-2028.
Emergence of human enzyme therapeutics and enzyme replacement therapy to treat rare disorders is one of the future trends of homocystinuria market. Enzyme replacement therapy and enzyme therapeutics is a type of novel drug therapy in which therapeutic enzymes are used to treat chronic and life-threatening diseases such as cancer, idiosyncratic disorders, and rare disorders. Furthermore, if an enzyme is not functioning properly in the body, then enzyme replacement therapy is used for replacing the enzyme that is deficient in the body. Enzymes have a predominant role in pharmaceutical industries and drug development as they treat various disorders. The advancements in the field of protein technology, recombinant DNA technology, enzyme immobilization, and nanotechnology have provided a solid platform for the use of enzymes in the treatment of various disorders.
The growth of the Homocystinuria market is mainly attributed to factors such as the increasing prevalence of inherited metabolic disorders coupled with rise in vitamin B6 and Vitamin B12 deficiencies. However, the lack of awareness about various rare disorders and inherited metabolic disorders is hindering the market growth.
The Asia Pacific region is expected to be the fastest-growing region among all other regions. The market in this region is expected to grow significantly in countries such as, China, Japan and India. The market is driven by increase in prevalence of inherited metabolic disorders, rise in government initiatives to manage rare diseases across the region along with increase in diagnostic tests across the region such as new born screening test etc. Therefore, the region holds huge potential for the homocystinuria market players to grow during the forecast period.
Homocystinuria is an inherited disorder in which the body is unable to process certain building blocks of proteins (amino acids) properly. There are multiple forms of homocystinuria, which are distinguished by their signs and symptoms and genetic cause. The most common form of homocystinuria is characterized by nearsightedness (myopia), dislocation of the lens at the front of the eye, an increased risk of abnormal blood clotting, and brittle bones that are prone to fracture (osteoporosis) or other skeletal abnormalities. Some affected individuals also have developmental delay and learning problems.
The List of Companies - Homocystinuria Market
- BASF SE
- HUAZHONG PHARMACEUTICAL
- Pfizer Inc.
- MYLAN N.V
- Aeglea BioTherapeutics
- Amino GMBH
- KAO Corporation
- DSM Corporation
- Orphan Technologies
- Fresenius Kabi AG.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)